Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia 1 Intraocular Lymphoma 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

zanubrutinib 1 Rituximab 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Intraocular Lymphoma × Methotrexate × Clear all

NCT06973811 2025-05-20

ZR-MTX

Peking Union Medical College Hospital

Phase 2 Not yet recruiting

Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡